Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

55101 - 55110 of 60079 results found

Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions

Date
Tuesday, April 11, 2023 - 4:00 AM
Description
Nirmatrelvir-ritonivir (Paxlovid) recently received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19). Literature has linked numerous cutaneous adverse effects to nirmatrelvir and ritonavir, the copackaged tablets

Diagnostic strategies in adrenal insufficiency

Date
Monday, April 10, 2023 - 4:00 AM
Description
PURPOSE OF REVIEW: Adrenal insufficiency (AI) is the clinical manifestation of deficient production of glucocorticoids with occasionally deficiency also in mineralocorticoids and adrenal androgens and constitutes a fatal disorder if left untreated